BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
10.32
+0.09 (0.88%)
Nov 4, 2024, 4:00 PM EST - Market closed
BrainsWay Employees
BrainsWay had 134 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
134
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$271,873
Profits / Employee
$4,537
Market Cap
174.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 987 |
Vaxart | 109 |
Acumen Pharmaceuticals | 52 |
Candel Therapeutics | 42 |
Atossa Therapeutics | 12 |
Sagimet Biosciences | 10 |
Inhibikase Therapeutics | 9 |
Akso Health Group | 9 |
BWAY News
- 6 days ago - BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024 - GlobeNewsWire
- 26 days ago - BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea - GlobeNewsWire
- 5 weeks ago - BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners - GlobeNewsWire
- 7 weeks ago - BrainsWay Announces Significant Expansion on U.S. East Coast - GlobeNewsWire
- 7 weeks ago - Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals - GlobeNewsWire
- 2 months ago - BrainsWay Appoints Richard A. Bermudes, M.D. - GlobeNewsWire
- 2 months ago - BrainsWay: Operating Leverage Driving Upside - Seeking Alpha
- 3 months ago - BrainsWay Ltd. (BWAY) Q2 2024 Earnings Call Transcript - Seeking Alpha